Association between aortic valve calcification and myocardial ischemia, especially in asymptomatic patients

Journal of Nuclear Medicine

Volumn 53, Issue 8, 2012, Pages 1216-1221

  Yamazato, Ryo ^a   Yamamoto, Hideya ^a   Tadehara, Futoshi ^a   Teragawa, Hiroki ^a   Kurisu, Satoshi ^a   Dohi, Yoshihiro ^a   Ishibashi, Ken ^a   Kunita, Eiji ^a   Utsunomiya, Hiroto ^a   Oka, Toshiharu ^a   Kihara, Yasuki ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Aortic valve calcification; Asymptomatic; Myocardial ischemia; SPECT

Indexed keywords

THALLIUM 201;

AGED; AORTA VALVE DISEASE; AORTIC VALVE CALCIFICATION; ARTICLE; ASYMPTOMATIC DISEASE; BLOOD VESSEL CALCIFICATION; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FEMALE; HEART MUSCLE ISCHEMIA; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS MYOCARDIAL PERFUSION SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AORTIC VALVE; ASYMPTOMATIC DISEASES; CALCINOSIS; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MYOCARDIAL ISCHEMIA; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 84864747675     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.111.099275     Document Type: Article

References (31)

1. Stewart BF, Siscovick D, Lind BK, et al. Clinical factors associated with calcific aortic valve disease. Cardiovascular Health Study. J Am Coll Cardiol. 1997;29:630-634. (Pubitemid 27116107)
2. Katz R, Wong ND, Kronmal R, et al. Features of the metabolic syndrome and diabetes mellitus as predictors of aortic valve calcification in the Multi-Ethnic Study of Atherosclerosis. Circulation. 2006;113:2113-2119.
3. Katz R, Budoff MJ, Takasu J, et al. Relationship of metabolic syndrome with incident aortic valve calcium and aortic valve calcium progression: the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes. 2009;58:813-819.
4. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aorticvalve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med. 1999;341:142-147. (Pubitemid 29325741)
5. Aronow WS, Ahn C, Shirani J, Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol. 1999;83:599-600. (Pubitemid 29097965)
6. Olsen MH, Wachtell K, Bella JN, et al. LIFE substudy: aortic valve sclerosis relates to cardiovascular events in patients with hypertension (a LIFE substudy). Am J Cardiol. 2005;95:132-136. (Pubitemid 40051130)
7. Shah SJ, Ristow B, Ali S, Na BY, Schiller NB, Whooley MA. Acute myocardial infarction in patients with versus without aortic valve sclerosis and effect of statin therapy (from the Heart and Soul Study). Am J Cardiol. 2007;99:1128-1133. (Pubitemid 46562515)
8. Hsu SY, Hsieh IC, Chang SH, Wen MS, Hung KC. Aortic valve sclerosis is an echocardiographic indicator of significant coronary disease in patients undergoing diagnostic coronary angiography. Int J Clin Pract. 2005;59:72-77.
9. Chang SM, Hakeem A, Nagueh SF. Predicting clinically unrecognized coronary artery disease: use of two-dimensional echocardiography. Cardiovasc Ultrasound. 2009;7:10-17.
10. Jeon DS, Atar S, Brasch AV, et al. Association of mitral annulus calcification, aortic valve sclerosis and aortic root calcification with abnormal myocardial perfusion single photon emission tomography in subjects age ≤ 65 years old. J Am Coll Cardiol. 2001;38:1988-1993. (Pubitemid 33116575)
11. Palmiero P, Maiello M, Passantino A, Wasson S, Reddy HK. Aortic valve sclerosis: is it a cardiovascular risk factor or a cardiac disease marker? Echocardiography. 2007;24:217-221. (Pubitemid 46280578)
12. Utsunomiya H, Yamamoto H, Kunita E, et al. Combined presence of aortic valve calcification and mitral annular calcification as a marker of the extent and vulnerable characteristics of coronary artery plaque assessed by 64-multidetector computed tomography. Atherosclerosis. 2010;213:166-172.
13. Yamamoto H, Shavelle D, Takasu J, et al. Valvular and thoracic aortic calcium as a marker of the extent and severity of angiographic coronary artery disease. Am Heart J. 2003;146:153-159. (Pubitemid 36851315)
14. Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med. 2001;42:831-837. (Pubitemid 32537427)
15. Hachamovitch R, Hayes SW, Friedman JD, Cohen I, Berman DS. Comparison of the short-term survival benefit associated with revascularization compared with medical therapy in patients with no prior coronary artery disease undergoing stress myocardial perfusion single photon emission computed tomography. Circulation. 2003;107:2900-2907.
16. Hendel RC, Berman DS, Di Carli MF, et al. ACCF/ASNC/ACR/AHA/ASE/SCCT/ SCMR/SNM 2009 appropriate use criteria for cardiac radionuclide imaging: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the American Society of Nuclear Cardiology, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the Society of Cardiovascular Computed Tomography, the Society for Cardiovascular Magnetic Resonance, and the Society of Nuclear Medicine. J Am Coll Cardiol. 2009;53:2201-2229.
17. Hendel RC, Abbott BG, Bateman TM, et al. The role of radionuclide myocardial perfusion imaging for asymptomatic individuals. J Nucl Cardiol. 2011;18:3-15.
18. Mahmarian JJ, Pratt CM, Cocanougher MK, Verani MS. Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography. Circulation. 1990;82:1305-1315.
19. Laukkanen JA, Kurl S, Lakka TA, et al. Exercise-induced silent myocardial ischemia and coronary morbidity and mortality in middle-aged men. J Am Coll Cardiol. 2001;38:72-79. (Pubitemid 32613830)
20. Davies RF, Goldberg AD, Forman S, et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation. 1997;95:2037-2043. (Pubitemid 27184271)
21. The International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32:1327-1334.
22. Holly TA, Abbott BG, Al-Mallah M, et al. Single photon-emission computed tomography. J Nucl Cardiol. 2010;17:941-973.
23. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis: histological and immunohistochemical studies. Circulation. 1994;90:844-853. (Pubitemid 24242754)
24. Olsson M, Rosenqvist M, Nilsson J. Expression of HLA-DR antigen and smooth muscle cell differentiation markers by valvular fibroblasts in degenerative aortic stenosis. J Am Coll Cardiol. 1994;24:1664-1671. (Pubitemid 24369191)
25. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol. 1996;16:523-532. (Pubitemid 26107723)
26. Olsson M, Thyberg J, Nilsson J. Presence of oxidized low density lipoprotein in nonrheumatic stenotic aortic valves. Arterioscler Thromb Vasc Biol. 1999;19:1218-1222. (Pubitemid 29227640)
27. Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol. 2003;41:136-141. (Pubitemid 36044415)
28. Shavelle DM, Takasu J, Budoff MJ, Mao S, Zhao XQ, O'Brien KD. HMG CoA reductase inhibitor (statin) and aortic valve calcium. Lancet. 2002;359:1125-1126. (Pubitemid 34270741)
29. Rosenhek R, Rader F, Loho N, et al. Statins but not angiotensin- converting enzyme inhibitors delay progression of aortic stenosis. Circulation. 2004;110:1291-1295. (Pubitemid 39202347)
30. Messika-Zeitoun D, Bielak LF, Peyser PA, et al. Aortic valve calcification: determinants and progression in the population. Arterioscler Thromb Vasc Biol. 2007;27:642-648.
31. Yamamoto K, Yamamoto H, Yoshida K, et al. Prognostic factors for progression of early- and late-stage calcific aortic valve disease in Japanese: the Japanese Aortic Stenosis Study (JASS) Retrospective Analysis. Hypertens Res. 2010;33:269-274.